[go: up one dir, main page]

GB201609322D0 - Therapy - Google Patents

Therapy

Info

Publication number
GB201609322D0
GB201609322D0 GBGB1609322.1A GB201609322A GB201609322D0 GB 201609322 D0 GB201609322 D0 GB 201609322D0 GB 201609322 A GB201609322 A GB 201609322A GB 201609322 D0 GB201609322 D0 GB 201609322D0
Authority
GB
United Kingdom
Prior art keywords
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1609322.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
E Therapeutics PLC
Original Assignee
E Therapeutics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E Therapeutics PLC filed Critical E Therapeutics PLC
Priority to GBGB1609322.1A priority Critical patent/GB201609322D0/en
Publication of GB201609322D0 publication Critical patent/GB201609322D0/en
Priority to PCT/GB2016/053271 priority patent/WO2017068349A1/en
Ceased legal-status Critical Current

Links

GBGB1609322.1A 2015-10-23 2016-05-26 Therapy Ceased GB201609322D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1609322.1A GB201609322D0 (en) 2016-05-26 2016-05-26 Therapy
PCT/GB2016/053271 WO2017068349A1 (en) 2015-10-23 2016-10-20 Cannabinoid for use in immunotherapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1609322.1A GB201609322D0 (en) 2016-05-26 2016-05-26 Therapy

Publications (1)

Publication Number Publication Date
GB201609322D0 true GB201609322D0 (en) 2016-07-13

Family

ID=56410615

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1609322.1A Ceased GB201609322D0 (en) 2015-10-23 2016-05-26 Therapy

Country Status (1)

Country Link
GB (1) GB201609322D0 (en)

Similar Documents

Publication Publication Date Title
IL263521A (en) Combination therapy
IL265406B (en) Combination therapy
GB201707153D0 (en) Therapy
GB201516442D0 (en) Combination therapy
IL257976A (en) Combination therapy
GB201719646D0 (en) Therapy
HK1255110A1 (en) Combination therapy
GB201708663D0 (en) Therapy
GB201609597D0 (en) Therapy
GB201604318D0 (en) Combination therapy
GB201604316D0 (en) Combination therapy
IL265340A (en) Combination therapy
GB201505382D0 (en) Novel therapy
GB201617470D0 (en) Novel therapy
GB201609735D0 (en) Combination therapy
GB201603653D0 (en) Combination Therapy
GB201715430D0 (en) Therapy
GB201618477D0 (en) Therapy
GB201615923D0 (en) Macrophage-based therapy
GB201707945D0 (en) Cnacer therapy
GB201707183D0 (en) Macrophage-based therapy
GB201609721D0 (en) Cobination therapy
GB201609322D0 (en) Therapy
GB201609312D0 (en) Therapy
GB201703453D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)